Immunization

Childhood vaccinations took a downturn during the pandemic. Now is the time to get them done and pharmacists can help.

The Breakthrough Therapy designation for VAX-24 will grant Vaxcyte access to the FDA’s Fast Track program.

Keep your pharmacy services up to date with the latest 2023 ACIP vaccination schedule updates and recommendations.

Take a look back at our most popular women's health coverage for 2022.

Take a look back at our most popular pediatric coverage for 2022.

Vaccination program has also prevented more than 18 million hospitalizations, saved $1 trillion in medical costs.

Winner of SingleCare's Best of the Best: Best Pharmacist, Nguyen joined Drug Topics® to discuss how he's helped patients during adverse conditions and what makes for a successful patient encounter.

Health, science, and politics are in the mix as studies examine links among debates over shots against COVID-19 and measles.

Less than half (45%) of all nursing facility residents and less than a quarter of staff (22%) are up to date with their COVID-19 vaccinations. That is a sharp drop from the 87% of nursing facility residents and staff who completed their primary vaccination series.

The shingles vaccine appears to confer long-term immunity, according to research.

Recent research looks at how the pandemic impacted the uptake of the human papillomavirus vaccine, which has traditionally lagged behind other pediatric vaccine rates.

Not every pharmacist may feel comfortable administering vaccines to children, but education could help.

Providing culturally competent care is one way pharmacists can help improve vaccine uptake in their communities.

Immunocompromised adults aged 19 years or older are eligible to receive the recombinant zoster vaccine.

Taking a look at the causes of vaccine hesitancy and the effects of vaccine hesitancy on public health.

A recent poll showed that some parents do not discuss vaccines with their child’s regular doctor, with many choosing to not have their child receive any vaccines.

The COVID-19 pandemic disrupted routine immunization programs around the world.

Confidence in vaccines is lower post-pandemic across all demographic groups

Communication and education are critical to patient confidence in emergency use authorization vaccines.

Mitchel Rothholz, RPh, MBA, and Jeff Goad, PharmD, MPH, share thoughts on COVID-19 vaccines and boosters in anticipation of an uptick in cases in the coming months.

Key opinion leaders share insights regarding considerations for COVID-19 boosters amid variants.

Addressing hesitancy is more than just offering pertinent information.

In a recent study, researchers found that text message reminders led to increased influenza vaccination rates, along with many receiving the vaccine sooner.

Human papillomavirus vaccines can help prevent cancer, but uptake still lags.

Phase I/II data indicate that new investigative pneumococcal conjugate vaccine shows efficacy in preventing disease in adults.